Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
bempegaldesleukin
×
Thoracic
×
Clear all
Filters
3
NCT02983045
2023-03-13
PIVOT-02
Nektar Therapeutics
Phase 1/2
Completed
557 enrolled
22 charts
NCT03138889
2023-03-10
PROPEL
Nektar Therapeutics
Phase 1/2
Terminated
162 enrolled
21 charts